Ford installs in-car heart rate monitor in its vehicles
The Ford Motor Company has announced that it is developing a car seat which will help consumers keep track of their health by monitoring their heart rate.
Ford has already recently announced an ‘allergy friendly’ range of cars which are fitted with pollen counters and it is also hoping to attach glucose monitors to its vehicles.
In this new development, the Ford team have come up with a product which monitors the electrical pulses from the driver’s heart and therefore can track certain health issues.
READ MORE FROM THE WDM CONTENT NETWORK:
To read the latest edition of Healthcare Global, click here
- Meditation helps to relieve stress and beat depression
- The Priory: A top-class research facility
- Diet and exercise tips to control weight loss
Six sensors are embedded in the back of the driver’s seat and have been designed to read the heartbeat through clothing.
It is thought the seat will be able to warn people about impending heart attacks; however, researchers have said that they are still working on a solution that works with all types of clothing materials.
During its product testing, the seat monitor has produced accurate readings for 98 percent of the time spent driving.
Ford says the system could be life saving; if the heart rate monitor detected an imminent problem with the driver’s health, it could automatically reduce the speed of the car to reduce the risk of a serious accident.
Another possible function of the monitor to send automatic updates to a doctor to help patients with existing heart problems manage their condition.
It could also even be used to provide real-time information to medical services in the event of an accident.
The managing director of Ford’s European research centre in Germany, Pim van der Jagt, said in an interview: “With the aging population and this interest in health and wellness, therecould be an interest in this type of technology.”
Ford has collaborated with German university Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University on the project.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”